The Importance of Specialized Cancer Treatment Settings in Adolescent and Young Adult Acute Lymphoblastic Leukemia

LECTURE SERIES
Written By Lauren Fulton

April 29th, 2025

This lecture will review results of population based and mixed methods research demonstrating the association between specialized cancer treatment settings and outcomes in adolescent and young adult acute lymphoblastic leukemia. Access barriers and health policy opportunities will be discussed.

Lori Muffly, MD

Dr. Muffly is an Associate Professor of Medicine in the Division of Blood and Marrow Transplantation at Stanford University. She directs a clinical research program focused on improving outcomes of adults with acute leukemia utilizing two distinct research methodologies: 1) innovative investigator initiated clinical trials; 2) health outcomes using large datasets and mixed methods approaches. Her clinic is devoted to adults with advanced acute lymphoblastic leukemia or acute myeloid leukemia who require allogeneic HCT or CAR T cell therapies. Dr. Muffly holds leadership positions in hematology and cell therapy societies around the world and serves on the editorial boards of numerous scientific journals. Her research is funded by the NIH, LLS, and through several industry partnerships.

Lauren Fulton

I am a Creative Director and Designer with 10 years of experience. My true passion lies in helping small to medium size brands discover who they are, and how they can make an impact through design.

I work across a spectrum of mediums including UX design, web design, branding, packaging, and photography/illustration art direction. I work with start-ups and medium-sized brands from fashion to blockchain and beyond.


https://www.laurenfultondesign.com/
Previous

Ingraining Equity Concerns into Performance Improvement Methodology: The Montefiore Experience
Next

Everything you always wanted to know about SMCI (Stanford Medicine Center for Improvement)!